Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$1.75 - $4.5 $201,958 - $519,322
-115,405 Reduced 59.2%
79,530 $187,000
Q1 2022

May 13, 2022

SELL
$4.26 - $5.82 $477,656 - $652,573
-112,126 Reduced 36.52%
194,935 $877,000
Q4 2021

Feb 14, 2022

BUY
$4.53 - $9.78 $1.39 Million - $3 Million
307,061 New
307,061 $1.58 Million

About MINERVA SURGICAL INC


  • Ticker UTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 28,860,000
  • Market Cap $289K
  • Description
  • Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation de...
More about UTRS
Track This Portfolio

Track Caas Capital Management LP Portfolio

Follow Caas Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Caas Capital Management LP with notifications on news.